StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca FluMist / Fluenz (influenza vaccine) by Quarter

FluMist / Fluenz (influenza vaccine) — Worldwide product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca FluMist / Fluenz (influenza vaccine): $18M in Q2 2026, up 80.0% from a year earlier.

Latest, Q2 2026
18
Period ended Jun 30, 2026
Change on a year earlier
+80.0%
10 in Q2 2025
History
32 quarters
Since Q1 2016
Sources
26
Documents cited below

Where the Q2 2026 figure comes from

“|| FluMist | | 18 | | 79 | | 78 | | ( 2 ) | | n/m | | 1 | | n/m | | n/m | | - | | - | | - | | 19 | | 90 | | 82”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFluMist / Fluenz (influenza vaccine) — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202618+80.0%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20268–Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025140-6.0%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025122+22.0%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202510+400.0%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20250-100.0%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024149+8.0%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024100+33.3%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20242–Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20247+250.0%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023138+19.0%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202375+27.1%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20230-100.0%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20232-300.0%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022116-34.8%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202259-18.1%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up fluMist / Fluenz (influenza vaccine)

Cite this data

StockData. (2026). AstraZeneca FluMist / Fluenz (influenza vaccine) ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-flumist-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.